Case Studies

MARKET OPPORTUNITY EVALUATION FOR A THERAPY EFFECTIVENESS AGENT IN ONCOLOGY

On January 9, 2014, In Case Studies,
A global biopharmaceutical company has an asset in development which has the potential to monitor the therapeutic effectiveness of a new class of receptor-targeted compounds in a wide range of tumour types. A simple, transparent model was required to help explore the potential label indications being pursued in their current development programme. Analysis of the USA and top five European markets was needed, as well as a number of other markets with limited data available but a known high prevalence of the indications being pursued.